The high incidence of acute Chagas disease in El Salvador has been known for several years. Previous studies have suggested that acute cases of Chagas disease are rarely observed in Latin American countries ([@B5]) because most cases are asymptomatic, with only 1-2% of infected individuals experiencing symptoms ([@B4]). Even though the possibility of contracting the parasite by ingestion of contaminated fruit was recently reported in Venezuela ([@B2]), oral transmission of *Trypanosoma cruzi* has not been reported in El Salvador or other Central American countries. As fewer than five acute cases are reported annually throughout the rest of Central America, the reason for the large number of acute cases in El Salvador is unclear.

In most cases, individuals exhibiting symptoms of infection, including dermatologic manifestations of chagoma or Romaña's sign, fever and malaise or who are suspected of having acute Chagas disease are referred to a health facility. Specimens collected from these individuals are sent to the nearest laboratory for examination by either direct microscopic examination of fresh blood or by the Strout method. All positive specimens are sent to the Central Laboratory of the Ministry of Health for confirmation and all acute cases are treated with nifurtimox under the supervision of a physician.

The annual number of acute cases reported between 2000-2012 in each province, is shown in [Table](#t01){ref-type="table"}. The data presented here are secondary data collected by health personnel rather than by researchers during a formal research study. As can be observed, 731 acute cases were detected in both children and adults over 13 years. The annual number of patients with acute Chagas disease declined from 117 in 2007 to 16 in 2012. In 2011, 50% of the cases occurred in children aged zero-nine years and 91.7% of the cases occurred in individuals younger than 20 years of age.

TABLENumber of acute Chagas cases reported per year by province, 2000-2012RegionProvince2000200120022003200420052006200720082009201020112012Sub-totalWesternAhuachapan3202115181014735383Santa Ana294329219101776147138Sonsonate622010169781121175CentralChalatenango000003146000014La Libertad114042110801225MetropolitanSan Salvador61951917243260208001211ParacentralCuscatlan010003724320123La Paz00000200520009San Vicente00101000100003Cabanas0016002222300027EasternUsulutan000024502421020San Miguel004001732199212187Morazan000080010200011La Union00002101100005Total45293523541101161178957162416731[^1]

Several factors may have contributed to the effective detection of acute Chagas disease cases, including (i) improved health facility access, permitted by small territories with a high density of medical facilities, (ii) the presence of trained health personnel who can recognise the diagnostic indicators of acute cases (Romaña's signs and chagoma) and (iii) the presence of health promoters, who are each assigned 200 families and are required to make routine house visits to implement public health activities at least once a month. Although these favourable conditions allow for the detection of acute cases, the factors responsible for the high number of acute cases has not been determined.

It is well known that successful vector control interventions have led to a reduced seroprevalence, followed by a decline in the incidence of acute infection ([@B6]). In contrast, a relatively high infestation rate of *Triatoma dimidiata* and serological prevalence for *T. cruzi* in El Salvador compared to that in neighbouring countries may be associated with a high incidence of acute infection. A 2008 entomological study of communities where insecticide spraying had not been performed found a mean *T. dimidiata*infestation rate of 23.4%, ranging from 15.2% in the Morazán province to 44.9% in San Miguel in El Salvador, to 4.3% in the Honduras ([@B1]). In Guatemala, the infestation rate was recorded as 10.3% between 2000-2003, during which no spraying had occurred, but it decreased to 0.7% after a second cycle of spraying was performed between 2001-2005 ([@B7]). Serological testing of children under 16 years of age in 2008 identified only one serologically positive case for *T. cruzi* (0.03%) in Honduras, compared to 30 (1.11%) in El Salvador ([@B1]). Nevertheless, a serological study of children under six years of age found the seroprevalence in El Salvador (0.36%) between 1999-2000 ([@B3]) to be slightly lower than that in Guatemala (0.5%) between 2004-2005 ([@B7]). However, routine house visits for active search of triatomine bugs by health promoters and health personnel of a vector-borne disease control program revealed that half of El Salvador has a high *T. dimidiata* dispersion index ([Figure](#f01){ref-type="fig"}). This finding implies the need for urgent improvements to the surveillance and vector control programs are required in the provinces where acute Chagas disease occurs and throughout the rest of the country.

Dispersion index of Triatoma dimidiata by province, in 2011. Source: Department of Parasitology, Central Laboratory of the Ministry of Health in El Salvador.

Two limitations of this study were the use of secondary data and the inability to obtain data regarding the clinical manifestation and demographic characteristics of the subjects for further analysis. A third limitation was that the cases reported were only those detected by chance because most patients are asymptomatic during the acute phase and thus, these data represent only a small proportion of all acute Chagas disease cases. Further understanding of the epidemiology of Chagas disease requires assessment of the geographical distribution of *T. dimidiata* and its infestation rate.

This study was performed by analysing the existing secondary data without personal information. Although this study was not presented before the ethics review board, we believe that those data will contribute to the improvement of Chagas disease control activities in El Salvador and Central American countries.
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